USA Today carries this story today about state’s struggles in keeping down rising Medicaid costs — especially in the area of prescription drugs:
“The increase in spending for Medicaid, the federal-state health care program for low-income Americans, has bedeviled states for decades. Spending for medication was no different, and states have tried preferred-drug lists that point beneficiaries to cost-effective medications, requiring prior authorizations of drugs, requiring discounts from manufacturers, negotiating additional rebates and entering multistate joint-buying programs.”
This is exactly the challenge that could be met — at least in part — by upgrading management of drug benefits in Medicaid … to the tune of $74.4 billion.
Read the full study here.